由于NLRC3缺乏,通过IKK/NF-κB p65/HIF-1α通路促进缺氧诱导的肺高血压的发展
Nuerbiyemu Maimaitiaili1, Yanxi Zeng1, Peinan Ju1
1Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai, China.
Experimental cell research
|August 16, 2023
概括
缺乏NLRC3会通过促进血管重塑和炎症,使缺氧诱导的肺高血压恶化. 这表明NLRC3是这种情况的潜在治疗点.
科学领域:
- 肺高血压研究 肺高血压研究
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 低氧引起的肺高血压 (PH) 治疗选择有限.
- 对于PH的潜在治疗点在很大程度上仍未被探索.
研究的目的:
- 研究NLRC3在缺氧引起的PH中的作用.
- 阐明NLRC3参与的基本机制.
主要方法:
- 来自高海拔肺高血压 (HAPH) 患者的肺组织分析.
- 使用野生类型和NLRC3淘汰赛小鼠模型在低氧状态下.
- 在实验室中使用大鼠肺动脉光滑肌细胞 (PASMC) 和人类静脉内皮细胞 (HUVEC) 的研究.
- 技术包括免疫组织化学,免疫光,右心脏导管,心声回声.
主要成果:
- 在HAPH患者的肺组织中,NLRC3的下调主要发生在肺血管光滑肌细胞和内皮细胞中.
- 在小鼠中,NLRC3淘汰赛加剧了因缺氧引起的右心室缩压升高,高和纤维化.
- 在体外,NLRC3缺乏促进了通过IKK/NF-κB p65/HIF-1α通路的PASMC增殖,HUVEC亡,迁移和炎症.
结论:
- 缺乏NLRC3有助于低氧诱导的肺高血压进展和血管重塑.
- IKK/NF-κB p65/HIF-1α通路与NLRC3的机制有关.
- NLRC3代表了低氧引起的PH的潜在治疗标.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
223
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
223
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Acute Respiratory Failure-II
272
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
272
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Acute Respiratory Failure-III
223
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
223
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12


